BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31669506)

  • 1. Sentinel biomarkers in HCV positive patients with mixed cryoglobulinemia.
    Basile U; Marino M; Gragnani L; Napodano C; Gulli F; Pocino K; Lorini S; Santini SA; Basile V; Miele L; Zignego AL; Rapaccini GL
    J Immunol Methods; 2020 Jan; 476():112687. PubMed ID: 31669506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers in HCV-related mixed cryoglobulinemia patients withnon-Hodgkin lymphoma.
    Gulli F; Marino M; Napodano C; Pocino K; Pandolfi F; Gasbarrini A; Rapaccini GL; Basile U
    Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):8067-8074. PubMed ID: 32767333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers of minimal residual disease in rituximab-treated patients with mixed cryoglobulinemia.
    Basile U; Gulli F; Napodano C; Pocino K; Basile V; Marrapodi R; Colantuono S; Todi L; Marino M; Rapaccini GL; Visentini M
    Biotechnol Appl Biochem; 2021 Apr; 68(2):319-329. PubMed ID: 32333692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus infection in mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma: evidence for a pathogenetic role.
    Zignego AL; Ferri C; Giannini C; La Civita L; Careccia G; Longombardo G; Bellesi G; Caracciolo F; Thiers V; Gentilini P
    Arch Virol; 1997; 142(3):545-55. PubMed ID: 9349300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of interleukin-6 by hepatitis C virus core protein in hepatitis C-associated mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma.
    Feldmann G; Nischalke HD; Nattermann J; Banas B; Berg T; Teschendorf C; Schmiegel W; Dührsen U; Halangk J; Iwan A; Sauerbruch T; Caselmann WH; Spengler U
    Clin Cancer Res; 2006 Aug; 12(15):4491-8. PubMed ID: 16899594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmunity and lymphoproliferation markers in naïve HCV-RNA positive patients without clinical evidences of autoimmune/lymphoproliferative disorders.
    Gulli F; Basile U; Gragnani L; Fognani E; Napodano C; Colacicco L; Miele L; De Matthaeis N; Cattani P; Zignego AL; Rapaccini GL
    Dig Liver Dis; 2016 Aug; 48(8):927-33. PubMed ID: 27289333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of association between Vitamin D status and free light chains profile with different chronic HCV-related liver and extrahepatic disorders.
    Basile U; Napodano C; Pocino K; Barini A; Marino M; Santini SA; Barini A; Stefanile A; Basile V; Callà CA; Cattani P; Gasbarrini A; Rapaccini GL; Gulli F
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8506-8514. PubMed ID: 31646582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum biomarker signature identifies patients with B-cell non-Hodgkin lymphoma associated with cryoglobulinemia vasculitis in chronic HCV infection.
    Terrier B; Chaara W; Dufat L; Geri G; Rosenzwajg M; Musset L; Sène D; Saadoun D; Six A; Klatzmann D; Cacoub P
    Autoimmun Rev; 2014 Mar; 13(3):319-26. PubMed ID: 24220267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serological profile of asymptomatic HCV positive patients with low level of cryoglobulins.
    Basile U; Napodano C; Pocino K; Gulli F; Santini SA; Todi L; Marino M; Rapaccini GL
    Biofactors; 2019 May; 45(3):318-325. PubMed ID: 30561820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum immunoglobulin free light chain levels in systemic autoimmune rheumatic diseases.
    Gulli F; Napodano C; Marino M; Ciasca G; Pocino K; Basile V; Visentini M; Stefanile A; Todi L; De Spirito M; Rapaccini GL; Basile U
    Clin Exp Immunol; 2020 Feb; 199(2):163-171. PubMed ID: 31618438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of immunoglobulin free light chains in patients with chronic hepatitis C presenting cryoglobulinemia.
    Oliveira IS; Cabral MS; Jesus LS; Paraná R; Atta AM; Sousa Atta ML
    Braz J Infect Dis; 2014; 18(6):638-42. PubMed ID: 25193081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different biochemical patterns in type II and type III mixed cryoglobulinemia in HCV positive patients.
    Basile U; Gulli F; Gragnani L; Pocino K; Napodano C; Miele L; Santini SA; Marino M; Zignego AL; Rapaccini GL
    Dig Liver Dis; 2018 Sep; 50(9):938-943. PubMed ID: 29709461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum-free light chain assessment in hepatitis C virus-related lymphoproliferative disorders.
    Terrier B; Sène D; Saadoun D; Ghillani-Dalbin P; Thibault V; Delluc A; Piette JC; Cacoub P
    Ann Rheum Dis; 2009 Jan; 68(1):89-93. PubMed ID: 18375535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etiopathogenetic role of hepatitis C virus in mixed cryoglobulinemia, chronic liver diseases and lymphomas.
    Ferri C; Zignego AL; Bombardieri S; La Civita L; Longombardo G; Monti M; Lombardini F; Greco F; Pasero G
    Clin Exp Rheumatol; 1995; 13 Suppl 13():S135-40. PubMed ID: 8730494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus-associated mixed cryoglobulinemia. Clinical manifestations, histopathological changes, mechanisms of cryoprecipitation and options of treatment.
    Schott P; Hartmann H; Ramadori G
    Histol Histopathol; 2001 Oct; 16(4):1275-85. PubMed ID: 11642746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of microRNA profile modifications in hepatitis C virus-related mixed cryoglobulinemia.
    Fognani E; Giannini C; Piluso A; Gragnani L; Monti M; Caini P; Ranieri J; Urraro T; Triboli E; Laffi G; Zignego AL
    PLoS One; 2013; 8(5):e62965. PubMed ID: 23650540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mixed cryoglobulinemia and hepatitis C virus.
    Cacoub P; Fabiani FL; Musset L; Perrin M; Frangeul L; Leger JM; Huraux JM; Piette JC; Godeau P
    Am J Med; 1994 Feb; 96(2):124-32. PubMed ID: 7509124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus within a malignant lymphoma lesion in the course of type II mixed cryoglobulinemia.
    De Vita S; Sansonno D; Dolcetti R; Ferraccioli G; Carbone A; Cornacchiulo V; Santini G; Crovatto M; Gloghini A; Dammacco F; Boiocchi M
    Blood; 1995 Sep; 86(5):1887-92. PubMed ID: 7655017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solving the mystery of HBV-related mixed cryoglobulinemia: potential biomarkers of disease progression.
    Pocino K; Napodano C; Gragnani L; Ciasca G; Colantuono S; Marri S; Vantaggio L; Gulli F; Lorini S; Barini A; Stefanile A; Miele L; Casato M; Zignego AL; Rapaccini GL; Marino M; Visentini M; Basile U
    Rheumatology (Oxford); 2021 Sep; 60(9):4418-4427. PubMed ID: 33590837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum concentrations of interleukin 1beta, CXCL10, and interferon-gamma in mixed cryoglobulinemia associated with hepatitis C infection.
    Antonelli A; Ferri C; Ferrari SM; Ghiri E; Marchi S; Sebastiani M; Fallahi P
    J Rheumatol; 2010 Jan; 37(1):91-7. PubMed ID: 19918044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.